Search Results

Cameco says it can ramp up core uranium asset production when demand recovers

Canadian uranium producer Cameco has said it is well positioned to respond to rising market demand, and will prioritize increasing output from its core assets if demand becomes clearer. Grant Isaac, Cameco's President and Chief Operating Officer, said on a company podcast discussing long-term strategy that Cameco remains committed to supply discipline, focusing on meeting customers' actual needs rather than setting overly ambitious growth expectations in the absence of confirmed demand. Isaac said the company is prepared to increase production from Tier 1 assets such as the McArthur River uranium mine and the Key Lake mill when market demand rises, lifting output from the current approximately 10 million to 11.5 million pounds of U3O8 to 25 million pounds.

2026-08-13

Full-Process Commissioning of Major Marine Isotope Separation Pilot Facility

Shanghai Jiao Tong University's Changxing Ocean Laboratory is dedicated to building a quasi-industrial research platform for high-end marine equipment. The Marine Isotope Separation Applied Research Center, focusing on the industrial context of isotope production, separation, and application, and supported by the ministerial-level Isotope Separation Science and Technology Center, conducts research and development of key isotope separation technologies and engineering equipment for Generation III reactors, Generation IV reactors, and fusion reactors, establishing an innovative platform integrating R&D, testing, validation, data, and technical services. Major research facility: Recently, the construction of the hundred-ton-per-year light water hydrogen isotope separation pilot platform has achieved phased results, with the system facility undergoing full-process commissioning. The platform adopts a self-developed water distillation coupled with cryogenic hydrogen isotope separation process, achieving large-scale efficient separation and enrichment of hydrogen isotopes from light water. The platform's outcomes hold broad engineering application value in fields such as pressurized water reactor wastewater treatment, deuterium-tritium isotope separation, fusion tritium plant operation, and heavy water/heavy hydrogen production. At 18:00 on August 4, 2026, at the Marine Isotope Separation Applied Research Center of Changxing Ocean Laboratory, the hundred-ton-per-year light water hydrogen isotope separation pilot facility was commissioned through its full process! The commissioning and operation of this pilot facility was undertaken by the Marine Isotope Separation Applied Research Center, with all departments coordinating collaboratively, making meticulous arrangements, and dedicating full efforts. During the operation, the team successively overcame multiple challenges including tight schedules, heavy workloads, and persistent high temperatures. This achievement not only fully validated the stability and reliability of the process platform but also demonstrated the researchers' responsibility and commitment in rising to challenges and persevering diligently. In the next phase, the project technical team will continue to deepen process optimization based on existing achievements, focus on advancing continuous and stable facility operation, accelerate engineering application, and provide strong support for breakthroughs in key core technologies in China's hydrogen isotope separation field.

2026-08-13

Leshan Accelerates Construction of Medical Isotope Production Base to Promote Domestic Substitution of "Anti-Cancer Nuclear Drugs"

On August 11, at the Leshan special press conference of "Myriad Scenes in Sichuan · Embarking on the '15th Five-Year Plan'", Leshan Mayor Zhao Yingchun stated that Leshan is accelerating the construction of the largest and most comprehensive medical isotope production base in China. Upon completion, the project will help break the foreign monopoly and import dependence on related products, promote the domestic substitution of anti-cancer nuclear drugs, and enable more patients to access domestically produced drugs with lower prices and better efficacy. Zhao Yingchun noted that during the "14th Five-Year Plan" period, Leshan has focused on building the "China Green Silicon Valley", a world-class tourist destination, and a major regional transportation and logistics hub in the province, continuously promoting high-quality development, with its economic output surpassing 250 billion yuan...

2026-08-12

US Oak Ridge National Laboratory Restarts Tungsten-188/Rhenium-188 Generator Production to Support Targeted Cancer Therapy Research

The US Department of Energy's Oak Ridge National Laboratory (ORNL) recently restarted and upgraded its tungsten-188/rhenium-188 (W-188/Re-188) generator manufacturing operations to meet the demand for the rare medical isotope rhenium-188 in targeted cancer therapy research. The laboratory last manufactured such generators in 2011. Radiochemist Becca Hores demonstrated the assembly process of the W-188/Re-188 generator. Depending on radioactivity levels, these generators must be assembled in gloveboxes or hot cells. Image credit: Maggie Gregg/Oak Ridge National Laboratory, US Department of Energy. Rhenium-188 is produced by the radioactive decay of tungsten-188. ORNL irradiates tungsten-186 in the High Flux Isotope Reactor (HFIR) to produce tungsten-188...

2026-08-12

South Korea to Resume Actinium-225 Production Next Year to Ease Shortage of Raw Materials for Anti-Cancer Radiopharmaceuticals

South Korea's domestic production project for actinium-225 (Ac-225), a radioisotope used in next-generation cancer treatment, is expected to resume next year after being stalled for more than a year. Funding was secured in the first half of this year, and the Korea Institute of Radiological & Medical Sciences (KIRAMS) plans to complete facility construction and trial production before launching full-scale production in the second half of next year, aiming to alleviate the raw material shortage facing domestic clinical research and radiopharmaceutical development. KIRAMS is affiliated with the Ministry of Science and ICT. The institute received approval from the Nuclear Safety and Security Commission in May last year to produce Ac-225 using a cyclotron. The project first entered the review process in 2018 and took seven years to gain approval, with initial production originally planned by the end of last year. However, work on upgrading production facilities and procuring equipment was suspended after approximately 2 billion KRW in budget was not approved during parliamentary review.

2026-08-10

228 Research Reactors Worldwide in Operation, Supporting Medical Isotope Production and Neutron Science Innovation

According to the International Atomic Energy Agency on August 7, research reactors continue to drive innovation in science, medicine, and industry worldwide. Currently, 228 research reactors are in operation across 54 countries, with another 23 under construction or in the planning stage. Unlike nuclear reactors used for power generation, these reactors primarily produce neutrons to support medical, industrial, agricultural, geological, forensic, and nuclear science research. A research reactor pool photographed from above. (Photo: IAEA) In the medical field, research reactors are a vital source of medical radioisotopes. Among them, technetium-99m is widely used for diagnosing cancer and diseases of the heart, brain, and bones; a large number of medical diagnostic and therapeutic procedures worldwide rely on this isotope. Other radioisotopes such as iodine-131 are also used in the treatment of cancer and thyroid diseases. The IAEA states that radioisotopes produced by research reactors serve millions of patients globally and are an essential component of modern nuclear medicine systems.

2026-08-09

Sevmash Advances Production of Main Thrust Bearings for Icebreaker "Stalingrad"

Sevmash, a subsidiary of the United Shipbuilding Corporation (USC), is continuing production of the main thrust bearings for the Stalingrad, the sixth serial universal icebreaker of Project 22220. One set of bearings for this vessel comprises three bearing units. Currently, two of these units have been delivered to Workshop 16 for bearing housing machining; the bearing raceways are also being machined and assembled in this workshop. The housing of the third unit is being assembled in the plant's hull welding shop. Meanwhile, in a dedicated area of Sevmash Workshop 4, bearing internal filling operations are underway, including the manufacture of bushings and bearing housings with anti-friction layers and filling with hot Babbitt metal. Each unit requires the installation of 24 bearing housings. This stage is one of the most labor-intensive processes in bearing manufacturing.

2026-08-07

Notice of the National Energy Administration on Issuing the "15th Five-Year" Action Plan for Electric Power Safety Production

Notice of the National Energy Administration on Issuing the "15th Five-Year" Action Plan for Electric Power Safety Production To the energy administrations of all provinces (autonomous regions, and municipalities directly under the central government), the development and reform commissions of relevant provinces (autonomous regions, and municipalities directly under the central government) and the Xinjiang Production and Construction Corps, the Beijing Municipal Urban Management Commission, the Tianjin Municipal Bureau of Industry and Information Technology, the Department of Industry and Information Technology of Liaoning Province, the Shanghai Municipal Commission of Economy and Informatization, the Chongqing Municipal Commission of Economy and Informatization, all dispatched agencies, and enterprise member units of the National Electric Power Safety Production Committee: In order to implement the decisions and arrangements of the Party Central Committee and the State Council on strengthening safety production, coordinate development and safety, deeply practice the new energy security strategy of "Four Revolutions and One Cooperation," consolidate the safety foundation for building a strong energy country, continuously improve the level of electric power safety production, and ensure the safe and stable operation of the power system and reliable power supply, the "15th Five-Year" Action Plan for Electric Power Safety Production is hereby formulated. It is now issued for your implementation.

2026-08-07

Oklo's Groves Isotope Test Reactor Achieves First Criticality

Oklo, a U.S. advanced nuclear technology company, announced on August 6 that its Groves Isotope Test Reactor has achieved a controlled self-sustaining nuclear chain reaction at low power, reaching first criticality. This milestone comes less than a year after the project broke ground. Groves Isotope Test Reactor facility (Image: Groves) The Groves low-power test reactor, located in Lockhart, Texas, is the first reactor to achieve criticality on private land under the U.S. Department of Energy's Reactor Pilot Program. According to Oklo, the facility was built from undeveloped land, completing civil excavation, engineering construction, component fabrication or procurement, fuel configuration, and...

2026-08-07

FAO and IAEA: Nuclear Technologies Are Enhancing Agricultural Production and Food Security

On March 30, 2021, the Food and Agriculture Organization of the United Nations and the International Atomic Energy Agency presented multiple applications of nuclear technologies in agriculture and food security. The two organizations have collaborated for over 50 years in knowledge sharing and capacity building, further strengthening their partnership through the establishment of the Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture. In the field of animal health, nuclear technologies are used for the detection, control, and prevention of transboundary animal diseases and zoonoses. Belize previously had to send animal disease testing samples to overseas laboratories; with support from the Joint FAO/IAEA Centre, the Belize Agricultural Health Authority established a molecular diagnostic laboratory for animal health and adopted real-time polymerase chain reaction (PCR) testing technology. This method can detect animal diseases within 24 hours, helping frontline personnel take rapid prevention and control measures. Recently, the laboratory has also been used to assist in human COVID-19 testing, reflecting the "One Health" concept that animal, human, plant, and environmental health are interconnected.

2021-03-30

South Korea Advances First Domestic Commercial Production of Lu-177 Using Wolsong Heavy Water Reactors

Korea Hydro & Nuclear Power (KHNP) plans to use the heavy water reactors at the Wolsong Nuclear Power Plant to produce, for the first time domestically, the radioisotope lutetium-177 (Lu-177) for cancer treatment. Currently, South Korea relies entirely on imports for this material, which imposes cost pressures and supply instability on local radiopharmaceutical companies such as Cellbion and FutureChem. Industry experts generally believe that domestic production will help build a diversified supply chain and shorten transportation times. The primary goal of this plan is to achieve commercial production of Lu-177, with pilot production expected in 2028 and full-scale production commencing in 2031. Subsequently, KHNP will expand production to include cobalt...

2026-08-06

US Firm Standard Nuclear's Two New TRISO Fuel Plants to Enter Production by 2026, Expanding Independent US Capacity

US nuclear fuel manufacturer Standard Nuclear announced that "major construction is substantially complete" at its two TRISO fuel production facilities, SN-TN in Tennessee and SN-ID in Idaho, and that the US Department of Energy has approved the Preliminary Documented Safety Analysis (PDSA) for both plants. The two facilities share an identical design and are expected to sequentially commence commissioning and licensing before the end of 2026. Authorized under the DOE's "Fuel Line Pilot Program," each plant will initially produce up to 1 metric ton of uranium (MTU) per year of TRISO fuel, with a combined ramp-up target of 5 MTU/year in the long term, forming a tiered supply alongside the company's existing SN-0 facility (0.5 MTU/year) operating in Oak Ridge. Standard Nuclear describes itself as "the only independent TRISO fuel manufacturer in the US," having been restructured from the fuel business of Ultra Safe Nuclear following its bankruptcy in 2024 (with USNC's reactor business acquired by Nano Nuclear). Its operations cover power reactor fuel as well as space and defense radioisotope power sources. The company also participates in the DOE's Fuel Line Pilot and Surplus Plutonium Disposition programs, has been allocated HALEU by the DOE for fuel fabrication, and has established a joint-venture TRISO line at Framatome's NRC-licensed fuel facility in Richland, Washington.

2026-08-06

South Korea advances plan to produce medical isotopes using nuclear power plants, with lutetium-177 targeted for commercial production in 2031

South Korea is advancing plans to industrialize the production of radioisotopes using nuclear power plants, with the medical isotope lutetium-177 (Lu-177) designated as the first commercial target product. Korea Hydro & Nuclear Power stated that it plans to prioritize the commercialization of Lu-177 production, with the potential to later expand the product range to include isotopes such as cobalt-60, tritium-3, and helium-3. Lu-177 is a therapeutic radioisotope widely used in the global radiopharmaceutical market, applicable in radiopharmaceuticals for diseases such as prostate cancer and neuroendocrine tumors. Previously, South Korea relied entirely on imports for its Lu-177 supply. Due to its half-life of approximately 6.6 days, the entire process from production and transportation to drug preparation and patient administration...

2026-08-06

Brazilian nuclear industry company starts fuel production for Angra 2's 22nd refueling

Brazilian Nuclear Industries (INB) has started production of nuclear fuel required for the 22nd refueling of Unit 2 at the Angra Nuclear Power Plant (Angra 2). On July 28, INB completed the assembly of the first fuel assembly at the Nuclear Fuel Factory (FCN) in Resende, Rio de Janeiro State; on July 30, the fuel assembly passed all established quality inspections in the production process and was certified. According to the plan, INB will manufacture a total of 52 fuel assemblies for this refueling. The assembly work is expected to be completed in December 2026 and delivered to Eletronuclear in March 2027. Recently, INB has made progress in several key stages of the nuclear fuel manufacturing chain. On July 28, approximately 240 tons of enriched...

2026-08-05

US Oak Ridge National Laboratory Advances New Process to Boost Californium-252 Production

Oak Ridge National Laboratory (ORNL), under the US Department of Energy, is advancing a new Californium-252 (Cf-252) separation process to address growing market demand. The laboratory stated that this process, developed over nearly a decade of research, is expected to shorten the Cf-252 production cycle by about one week, significantly improving processing efficiency without altering product quality. Californium-252 is a neutron-emitting radioisotope used in nuclear reactor startup, fuel testing for new reactors, as well as in oil well logging, coal analysis, port security, fuel rod scanners, and instrument calibration. ORNL noted that it is the only producer of Cf-252 in the Western world...

2026-08-05